Skip to main content
SpringerLink
Log in

NICE refutes claims of pharma influence on CVD risk guidelines

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • NICE. Behind the Headlines: Is NICE influenced by pharma? Internet Document : 14 Mar 2014. Available from: URL: http://www.nice.org.uk

Download references

Additional information

* see PharmacoEconomics & Outcomes News 697 p3-4; 801085760

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE refutes claims of pharma influence on CVD risk guidelines. PharmacoEcon Outcomes News 699, 2 (2014). https://doi.org/10.1007/s40274-014-1122-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1122-6

Search

Navigation